Skip to content

BBNX BBNX Deferred Tax Assets and Other Non-Current Assets

Deferred Tax Assets and Other Non-Current Assets at other companies

Insulet logo
InsuletPODD
Tandem Diabetes Care logo
Tandem Diabetes CareTNDM
Medtronic logo
MedtronicMDT
AdaptHealth logo
AdaptHealthAHCO

Other financials

Income statement

See full
Revenue$27.6M+56.6%
Gross profit$16.4M+83.2%
Operating income-$24.3M-30.2%
Net income-$21.9M+23.6%
EPS (diluted)-$0.49+47.3%

Balance sheet

See full
Cash & equivalents$30.2M-28.9%
Total debt$6.9M-0.9%
Total equity$271.2M-13.5%
Total assets$304.4M-9.9%

Cash flow

See full
Operating cash flow-$23.8M-19.3%
CapEx$1.4M+314%
Free cash flow-$25.2M-24.1%

Valuation

See full
Market cap$708.98M-8.6%
Enterprise value$685.68M
P/S6.4×

Profitability

See full
Gross margin57.2%+3.2pp
Operating margin-70.1%-6.4pp
Net margin-60.3%-17.4pp
FCF margin-55.4%-14.3pp

Returns & leverage

See full
Return on equity-22.7%
Debt / equity0.0×
Current ratio10.7×-5.2×

Where this comes from

Reported directly by BBNX in its filing.

Tagged under the XBRL concept us-gaap:OtherAssetsNoncurrent.

The official record: BBNX’s 10-Q, filed April 21, 2026, on SEC EDGAR. View the filing →

Ask your AI about BBNX's deferred tax assets and other non-current assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is BBNX's deferred tax assets and other non-current assets?
BBNX (BBNX) reported deferred tax assets and other non-current assets of $181K in Q1 2026.
How has BBNX's deferred tax assets and other non-current assets changed year-over-year?
BBNX's deferred tax assets and other non-current assets increased by 24.0% year-over-year, from $146K to $181K.
What is the long-term trend for BBNX's deferred tax assets and other non-current assets?
Over 2 years (2023 to 2025), BBNX's deferred tax assets and other non-current assets has grown at a 22.0% compound annual growth rate (CAGR), from $121K to $180K.